Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

By sjmartinez • January 20, 2023

Kanda E, Rastogi A, Murohara T, Lesén E, Agiro A, Arnold M, Chen G, Yajima T, Järbrink K, Pollack CV Jr. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. BMC Nephrol. 2023 Jan 19;24(1):18. doi: 10.1186/s12882-022-03054-5. PMID: 36658531.

Tags: Chronic kidney disease, Guideline-directed medical therapy, heart failure, Hyperkalemia, Nephrology, Potassium binder, Publications

Allele-specific HLA-B39 antibody reactivity in a highly sensitized kidney transplant candidate

Du A, Ishaq W, Flores DA, Saquilayan M, Ling C, Muramoto J, Kendall K, Butler CL, Reed EF, Zhang QJ, Barba LM, Sosa RA. Allele-specific[...]

Renal Toxicity of Rosuvastatin: A Case Report

Schulze C, Shye M. Renal Toxicity of Rosuvastatin: A Case Report. Cureus. 2025 Nov 3;17(11):e96013. doi: 10.7759/cureus.96013. PMID: 41356965; PMCID: PMC12675985.

Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease

Rattanasompattikul M, Srithongkul T, Tantisattamo E, Kalantar-Zadeh K, Noppakun K. Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens.[...]